MIRANDA MICUCCI: Open Payments
NPI 1437882537 · CHARLOTTESVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$602 in 30 payments from 17 companies in 2025. Trend: 2023 $317 · 2024 $498 · 2025 $602
Food & beverage: $602
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 5 | $106 |
| ABBVIE INC. | 3 | $75 |
| Novo Nordisk Inc | 3 | $66 |
| Merck Sharp & Dohme LLC | 2 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| Lilly USA, LLC | 2 | $33 |
| Actelion Pharmaceuticals US, Inc. | 1 | $29 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
Products named: PREVNAR 20, NURTEC ODT, UBRELVY, JARDIANCE, Kerendia, QULIPTA, MOUNJARO, UPTRAVI.
Industry payments across VA — which companies pay providers there.
